Acadia Healthcare Company, Inc. (ACHC)
$
12.55
-0.68 (-5.42%)
Key metrics
Financial statements
Free cash flow per share
-3.8403
Market cap
1.2 Billion
Price to sales ratio
0.3544
Debt to equity
0.7779
Current ratio
1.4441
Income quality
2.8397
Average inventory
6 Million
ROE
0.0349
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Acadia Healthcare Company, Inc. provides behavioral healthcare services across the United States and Puerto Rico, highlighting the company's operational efficiency with an EBITDA ratio of 0.19. The company's stock is identified with the symbol 'ACHC' in the market, allowing investors to track its performance effectively. Acadia reported a substantial revenue of $3,153,963,000.00 reflecting its strong market presence and ability to cater to diverse patient needs. The income before tax ratio stands at 0.11 illustrating the pre-tax margin and underlying profitability. Moreover, the company reported selling, general, and administrative expenses of $189,706,000.00 indicating its operational overhead costs as it manages a network of facilities that includes inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics. As of March 31, 2022, Acadia operates 238 behavioral healthcare facilities with approximately 10,600 beds, demonstrating its commitment to offering comprehensive healthcare solutions. The stock is affordable at $22.14 making it suitable for budget-conscious investors looking for entry points in the market. With a high average trading volume of 2,793,144.00 the stock indicates strong liquidity, which appeals to active traders and long-term investors alike. With a mid-range market capitalization of $1,157,418,140.00 the company is a steady performer amidst market fluctuations. It is a key player in the Medical - Care Facilities industry, contributing significantly to the overall market landscape, addressing the growing need for mental health services. Acadia Healthcare belongs to the Healthcare sector, driving innovation and growth as it advances its mission to provide quality care and improve outcomes for its patients. This essential role in the behavioral healthcare field positions it favorably for continued success and relevance in a rapidly evolving industry.
Is Acadia Healthcare Company, Inc. (ACHC) a good investment?
Investing in Acadia Healthcare Company, Inc. (ACHC) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B+, with a Bearish outlook. Always conduct your own research before investing.
What is Acadia Healthcare Company, Inc. (ACHC)'s stock forecast?
Analysts predict Acadia Healthcare Company, Inc. stock to fluctuate between $12.49 (low) and $45.61 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Acadia Healthcare Company, Inc.'s market capitalization?
As of 2026-01-13, Acadia Healthcare Company, Inc.'s market cap is $1,157,418,140, based on 92,224,553 outstanding shares.
How does Acadia Healthcare Company, Inc. compare to competitors like Eli Lilly & Co.?
Compared to Eli Lilly & Co., Acadia Healthcare Company, Inc. has a Lower Market-Cap, indicating a difference in performance.
How can I buy Acadia Healthcare Company, Inc. (ACHC) stock?
To buy Acadia Healthcare Company, Inc. (ACHC) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for ACHC. Place an order (Market, Limit, etc.).
What is the best time to invest in Acadia Healthcare Company, Inc.?
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
Has Acadia Healthcare Company, Inc. stock ever split?
Acadia Healthcare Company, Inc.'s last stock split was 1:4 on 2011-11-01.
How did Acadia Healthcare Company, Inc. perform in the last earnings report?
Revenue: $3,153,963,000 | EPS: $2.79 | Growth: -1,262.50%.
Where can I find Acadia Healthcare Company, Inc.'s investor relations reports?
Visit https://www.acadiahealthcare.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Acadia Healthcare Company, Inc.?
You can explore historical data from here
What is the all-time high and low for Acadia Healthcare Company, Inc. stock?
All-time high: $89.85 (2022-11-30) | All-time low: $12.49 (2026-01-13).
What are the key trends affecting Acadia Healthcare Company, Inc. stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
seekingalpha.com
Acadia Healthcare Company, Inc. (ACHC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
fool.com
New York City-based Engine Capital Management initiated a stake in Acadia Healthcare during the third quarter, acquiring nearly 2.6 million shares worth $64 million. The change represents 7.6% of reportable U.S. equity assets under management.
businesswire.com
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ACADIA HEALTHCARE COMPANY, INC. (ACHC), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss.
proactiveinvestors.com
Acadia Healthcare (NASDAQ:ACHC) shares plunged more than 10% after the company was downgraded to an ‘Underperform' rating by Bank of America analysts, who warned that rising insurance and legal costs will pressure profitability into 2026. The analyst also lowered their price objective on Acadia Healthcare to $13.
businesswire.com
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON ACADIA HEALTHCARE COMPANY, INC. (ACHC), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is the Investigation About? On December 2, 2025, after market hours, A.
barrons.com
It's the second time in a month that the psychiatric hospital operator has cut its earnings guidance.
seekingalpha.com
Acadia Healthcare Company, Inc. ( ACHC ) UBS Global Healthcare Conference 2025 November 11, 2025 2:45 PM EST Company Participants Christopher Hunter - CEO & Director Todd Young - Chief Financial Officer Conference Call Participants Joseph Overman - UBS Investment Bank, Research Division Presentation Joseph Overman UBS Investment Bank, Research Division Hey, everyone. I'm Joseph Overman, I'm on the health care managed care and facilities team here at UBS.
zacks.com
ACHC beats Q3 estimates on stronger patient volumes, but rising costs and lower guidance remain concerning.
seekingalpha.com
Acadia Healthcare Company, Inc. ( ACHC ) Q3 2025 Earnings Call November 6, 2025 9:00 AM EST Company Participants Brian Farley - Executive VP, General Counsel & Secretary Christopher Hunter - CEO & Director Todd Young - Chief Financial Officer Conference Call Participants Albert Rice - UBS Investment Bank, Research Division Pito Chickering - Deutsche Bank AG, Research Division Brian Tanquilut - Jefferies LLC, Research Division Benjamin Mayo - Leerink Partners LLC, Research Division Ryan Langston - TD Cowen, Research Division Jason Cassorla - Guggenheim Securities, LLC, Research Division Andrew Mok - Barclays Bank PLC, Research Division Matthew Gillmor - KeyBanc Capital Markets Inc., Research Division Joanna Gajuk - BofA Securities, Research Division Presentation Operator Hello, and thank you for standing by. My name is Lacey, and I will be your conference operator today.
zacks.com
ACHC, FWRD and CENX have been added to the Zacks Rank #5 (Strong Sell) List on Nov. 6, 2025.
See all news
